Stockscreener 앱 받기
5.49
1.29%
0.07
시간 외 거래:
5.59
0.10
+1.82%
전일 마감가:
$5.42
열려 있는:
$5.39
하루 거래량:
2.72M
Relative Volume:
1.04
시가총액:
$818.32M
수익:
-
순이익/손실:
$-207.02M
주가수익비율:
-3.8994
EPS:
-1.4079
순현금흐름:
$-176.59M
1주 성능:
+0.92%
1개월 성능:
+7.65%
6개월 성능:
+91.96%
1년 성능:
+119.60%
1일 변동 폭
$5.30
$5.62
1주일 범위
$5.30
$5.94
52주 변동 폭
$1.285
$7.18
아넥손 Stock (ANNX) Company Profile
명칭
Annexon Inc
전화
(650) 822-5500
주소
1400 SIERRA POINT PARKWAY, BRISBANE
Compare ANNX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANNX
Annexon Inc
|
5.49 | 807.88M | 0 | -207.02M | -176.59M | -1.4079 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
아넥손 Stock (ANNX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-23 | 개시 | Chardan Capital Markets | Buy |
| 2024-03-01 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-12-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-10-30 | 개시 | Wells Fargo | Overweight |
| 2023-05-26 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-05-25 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-09-16 | 개시 | Jefferies | Buy |
| 2022-09-09 | 개시 | BTIG Research | Buy |
| 2021-11-30 | 개시 | H.C. Wainwright | Buy |
| 2021-09-23 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-01-26 | 개시 | Needham | Buy |
| 2020-08-18 | 개시 | BofA Securities | Buy |
| 2020-08-18 | 개시 | Cowen | Outperform |
| 2020-08-18 | 개시 | JP Morgan | Overweight |
모두보기
아넥손 주식(ANNX)의 최신 뉴스
Annexon Investor Day: ANX007 Targets C1q in Dry AMD GA as Phase III Readout Nears Q4 - Yahoo Finance
ANNX: Phase III trial for C1q inhibition in GA is fully enrolled, with results expected in Q4 - TradingView
ANNX: Phase III trial for C1q inhibition in GA targets vision preservation with robust clinical design - TradingView
Portfolio Update: Will Annexon Inc benefit from government policyWeekly Stock Summary & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
Annexon reports inducement grant to new employee under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Biopharmaceutical Annexon offers new hire 20,000-share option grant - Stock Titan
Wall Street Recap: Is Annexon Inc in a bullish channel2026 Macro Moves & Technical Confirmation Alerts - baoquankhu1.vn
Insider Buying: William Carson Acquires 8,000 Shares of Annexon Inc (ANNX) - GuruFocus
William Carson Acquires 8,000 Shares of Annexon (NASDAQ:ANNX) Stock - MarketBeat
[Form 4] Annexon, Inc. Insider Trading Activity - Stock Titan
Annexon (NASDAQ:ANNX) Stock Price Down 8.1%Should You Sell? - MarketBeat
ANNX SEC FilingsAnnexon, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Annexon (NASDAQ:ANNX) Shares Up 6.8%Time to Buy? - MarketBeat
Rhenman & Partners Asset Management AB Boosts Holdings in Annexon, Inc. $ANNX - MarketBeat
Annexon (ANNX) CFO Lew sells shares to cover RSU tax withholding - Stock Titan
Annexon, Inc. (ANNX) CMO sells shares to cover tax obligations - Stock Titan
Annexon (ANNX) EVP Overdorf sells shares to cover RSU tax - Stock Titan
Annexon (ANNX) EVP sells 5,566 shares to cover RSU tax withholding - Stock Titan
Annexon Spotlights GA Phase III, GBS Regulatory Plans and ANX1502 Update at TD Cowen Conference - MarketBeat
Annexon (ANNX) EVP sells 5,894 shares to cover RSU taxes - Stock Titan
ANNX: Late-stage neuroinflammatory programs near key data and filings, with strong commercial focus - TradingView
Director files sale notice for 5,566 ANNX shares (NASDAQ: ANNX) - Stock Titan
ANNX (NASDAQ: ANNX) Rule 144 notice shows 5,894 shares to be sold; prior 5,290 sold - Stock Titan
ANNX (NASDAQ) Rule 144: Insider sale of 6,225 shares; 4,339 vested - Stock Titan
ANNX (NASDAQ: ANNX) Form 144 lists 5,565-share notice and recent insider sale - Stock Titan
Annexon, Inc. (NASDAQ:ANNX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
ANNX (NASDAQ: ANNX) insider sale notice: 5,820 shares tied to vesting - Stock Titan
ANNX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Annexon Showcases Promising Drug Ahead of Pivotal Trial Data - StocksToTrade
Annexon Showcases Emerging Treatment with Topline Data on Horizon - timothysykes.com
ANNX Technical Analysis & Stock Price Forecast - Intellectia AI
Annexon Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView
Does Annexon Inc. meet Warren Buffett’s criteriaEarnings Performance Report & Weekly Watchlist for Consistent Profits - mfd.ru
Annexon Biosciences to Present at the TD Cowen 46th Annual Health Care Conference - Investing News Network
Annexon targeting neuroinflammatory disease, CEO to speak at TD Cowen - Stock Titan
Annexon (ANNX) CFO receives 250,000 options and 62,500 RSUs in equity grant - Stock Titan
Annexon (ANNX) grants CMO 225,000 options and 56,250 RSUs - Stock Titan
Jamie Dananberg Sells 5,290 Shares of Annexon (NASDAQ:ANNX) Stock - MarketBeat
Insider Selling: Annexon (NASDAQ:ANNX) EVP Sells 5,290 Shares of Stock - MarketBeat
Annexon (NASDAQ:ANNX) EVP Sells $40,149.27 in Stock - MarketBeat
Annexon (NASDAQ:ANNX) CFO Sells $40,118.61 in Stock - MarketBeat
Annexon (ANNX) EVP sells 7,857 shares to cover RSU tax withholding - Stock Titan
Will Annexon Inc benefit from government policyTrade Volume Summary & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Aug Spikes: Will Annexon Inc benefit from government policyJuly 2025 PreEarnings & Technical Pattern Based Signals - baoquankhu1.vn
Published on: 2026-02-21 08:39:55 - baoquankhu1.vn
Is Annexon Inc stock a good dividend stock2025 Biggest Moves & High Return Trade Opportunity Guides - baoquankhu1.vn
[144] Annexon, Inc. SEC Filing - Stock Titan
Annexon Biosciences Announces Planned Retirement of Board Chairman - TipRanks
Annexon, Inc. Announces Retirement of Chairman of the Board Thomas G. Wiggans - marketscreener.com
Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy - The Manila Times
아넥손 (ANNX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):